[Chronic myeloid leukemia and imatinib mesylate therapy]

Candida arteritis in kidney transplant recipients: case report and review of the literature.

Transplant infectious disease : an official journal of the Transplantation Society·2015

The modification of diet in renal disease and chronic kidney disease epidemiology collaboration formulas versus measured or estimated creatinine clearance in kidney transplant recipients.

Transplantation proceedings·2014

Epidemiology of posttransplantation chronic kidney disease can be altered by choice of formula estimating glomerular filtration rate.

Transplantation proceedings·2014

[Combination of imatinib and anagrelide in treatment of chronic myeloid leukemia in blastic phase].

Vnitrni lekarstvi·2006

[The idiopathic hypereosinophilic syndrome and chronic eosinophilic leukemia].

Vnitrni lekarstvi·2006

The significance of soluble CD138 in diagnosis of monoclonal gammopathies.

Neoplasma·2006

Pharmacological profile of mepolizumab.

Vnitrni lekarstvi·2023

Atypical form of Goodpasture's disease.

Vnitrni lekarstvi·2023

Differentiated thyroid cancer - possible risks of treatment, suppressive therapy and adherence to current recommendations.

Vnitrni lekarstvi·2023

Dyslipidemia - the known unknown.

Vnitrni lekarstvi·2023

Internal comorbidities and complications of multiple sclerosis therapy - don't be caught off guard!

Vnitrni lekarstvi·2023

Implications of highly suppressive treatment HIV infection.

Vnitrni lekarstvi·2023

Linear IgA Bullous Dermatosis: A Rare Immune-Related Cutaneous Adverse Event Due to Pembrolizumab.

Cureus·2026

Short-Term Intensive Insulin Therapy as a Remission Induction Strategy in Newly Diagnosed Type 2 Diabetes Mellitus: A Systematic Review.

Cureus·2026

Targeting Human Immunodeficiency Virus Integrase Beyond the Active Site: The Discovery and Development of Allosteric Integrase Inhibitors.

ChemMedChem·2026

Invariant chain controls HLA-DQ folding and shapes the HLA class II proxiome.

Journal of immunology (Baltimore, Md. : 1950)·2026

Ultrasound-responsive PLGA nanoparticles co-loaded with celecoxib and catalase enhance the therapeutic efficacy of imatinib in gastrointestinal stromal tumors.

International journal of pharmaceutics·2026

Machine Learning-Guided Personalized Immunochemotherapy Strategies in Intrahepatic Cholangiocarcinoma.

JHEP reports : innovation in hepatology·2026

Related Experiment Videos

[Chronic myeloid leukemia and imatinib mesylate therapy]

Related Concept Videos

Candida arteritis in kidney transplant recipients: case report and review of the literature.

The modification of diet in renal disease and chronic kidney disease epidemiology collaboration formulas versus measured or estimated creatinine clearance in kidney transplant recipients.

Epidemiology of posttransplantation chronic kidney disease can be altered by choice of formula estimating glomerular filtration rate.

[Combination of imatinib and anagrelide in treatment of chronic myeloid leukemia in blastic phase].

[The idiopathic hypereosinophilic syndrome and chronic eosinophilic leukemia].

The significance of soluble CD138 in diagnosis of monoclonal gammopathies.

Pharmacological profile of mepolizumab.

Atypical form of Goodpasture's disease.

Differentiated thyroid cancer - possible risks of treatment, suppressive therapy and adherence to current recommendations.

Dyslipidemia - the known unknown.

Internal comorbidities and complications of multiple sclerosis therapy - don't be caught off guard!

Implications of highly suppressive treatment HIV infection.

Linear IgA Bullous Dermatosis: A Rare Immune-Related Cutaneous Adverse Event Due to Pembrolizumab.

Short-Term Intensive Insulin Therapy as a Remission Induction Strategy in Newly Diagnosed Type 2 Diabetes Mellitus: A Systematic Review.

Targeting Human Immunodeficiency Virus Integrase Beyond the Active Site: The Discovery and Development of Allosteric Integrase Inhibitors.

Invariant chain controls HLA-DQ folding and shapes the HLA class II proxiome.

Ultrasound-responsive PLGA nanoparticles co-loaded with celecoxib and catalase enhance the therapeutic efficacy of imatinib in gastrointestinal stromal tumors.

Machine Learning-Guided Personalized Immunochemotherapy Strategies in Intrahepatic Cholangiocarcinoma.

Related Experiment Videos

[Chronic myeloid leukemia and imatinib mesylate therapy]

Related Concept Videos

Related Articles